Pricing Log in Create free account

Coya Therapeutics, Inc. (COYA) vs PolyPid Ltd. (PYPD)

Coya Therapeutics, Inc. and PolyPid Ltd. are both Biotechnology companies. Coya Therapeutics, Inc. and PolyPid Ltd. are of similar size ($101.8M and $99.5M). PolyPid Ltd. has the higher net margin (0.00% vs −270.2%) and the higher return on invested capital (0.00% vs −15,230.9%). Across the 12 metrics below, Coya Therapeutics, Inc. leads on 6 and PolyPid Ltd. on 6.

Valuation

Metric COYA PYPD Biotechnology median
P/E n/m n/m 8.50
P/S 12.49 n/m 9.71
P/B 2.31 19.96 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 8.72 n/m 9.21
Earnings yield (25.06%) (31.16%) (33.15%)
Free cash flow yield (17.74%) (71.51%) (25.50%)

Profitability

Metric COYA PYPD Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (288.70%) 0.00% 0.00%
Net margin (270.22%) 0.00% 0.00%
Free cash flow margin (221.64%) 0.00% 0.00%
Return on equity (60.54%) (243.59%) (56.36%)
Return on assets (53.66%) (119.05%) (48.04%)
Return on invested capital (15,230.92%) 0.00% 0.00%

Growth

Metric COYA PYPD Biotechnology median
Revenue growth (TTM) 108.35% — 6.02%
EPS growth (last fiscal year) (29.59%) 57.43% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COYA PYPD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.40 1.35 4.72
Net debt to EBITDA 2.08 0.39 0.96

Dividend

Metric COYA PYPD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric COYA PYPD Biotechnology median
Market cap 101.80m 99.53m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack